TUSTIN, Calif., Aug. 28 /PRNewswire/ -- Avid Bioservices, Inc., a leading provider of cGMP contract manufacturing of biologics and other key services, today announced that it has further strengthened its executive team with the appointments of Truc Le as chief operating officer and Christopher Eso as vice president of business operations. These additions reflect Avid’s recent successes in expanding its customer base and growing its manufacturing revenues, as well as the future growth it anticipates over the coming years. Mr. Le brings Avid more than 30 years of operations and executive management experience at leading companies, with expertise in managing global operations and implementing quality assurance and regulatory affairs initiatives. Mr. Eso brings Avid more than 14 years of professional experience primarily in corporate development, strategic planning, project management and external relations, with more than nine years specifically in the life sciences and pharmaceutical industries.
Prior to joining Avid, Mr. Le was senior vice president of operations and corporate quality for biopharmaceutical company Nektar Therapeutics, where his overall responsibilities included drug manufacturing and management of the supply chain, materials, purchasing, quality management and compliance. Previously, Mr. Le was the worldwide vice president of regulatory compliance and quality systems at a division of Johnson & Johnson, where he was a member of the executive team. Mr. Le is a co-founder of, MLH Group, a consulting firm specializing in global operations, regulatory affairs, quality management and business excellence for the pharmaceutical, biotechnology, medical device and diagnostics industries.
Mr. Le has assisted numerous companies, ranging from start-up to Fortune 100 corporations, in developing and implementing operations and regulatory standards that meet U.S. FDA and international standards, as well as building world-class life sciences manufacturing operations worldwide. He is an expert in achieving business excellence using Six Sigma techniques to improve operational efficiency and effectiveness. Mr. Le holds a B.S. in mechanical engineering from Kanto University in Japan, an M.B.A. in management from the University of Redlands and has completed a number of executive training programs including World Class Manufacturing at Duke University and Executive Management at Harvard University.
“It has been gratifying to work with the Avid team during the past months as the company has continued to achieve impressive gains,” said Mr. Eso. “I look forward to building on this foundation over the coming years and partnering with Truc and the entire Avid team to further reinforce Avid’s stature as a primary supplier of choice by helping to expand our business offerings, develop a variety of new strategic relationships and partnerships, implement process improvements and grow our business in adjacent new markets.”
Avid Bioservices is a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. .
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara((R)). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. that provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.
Avid Bioservices, Inc.
